Marker Therapeutics, Inc. (MRKR)
NASDAQ · Healthcare
Marker Therapeutics, Inc. Net Income 2017–2025
Marker Therapeutics, Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Marker Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -3.2 M, a 28.49% decrease year-over-year.
- Marker Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -13.6 M, a 38.11% increase year-over-year.
- Marker Therapeutics, Inc. annual net income for 2025 was -12.2 M, a 13.35% increase from 2024.
- Marker Therapeutics, Inc. annual net income for 2024 was -10.7 M, a 30.28% increase from 2023.
- Marker Therapeutics, Inc. annual net income for 2023 was -8.2 M, a 72.48% decrease from 2022.
- Marker Therapeutics, Inc. annual net income for 2022 was -29.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Marker Therapeutics, Inc. Net Income — FAQ
Marker Therapeutics, Inc. (MRKR) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Marker Therapeutics, Inc.'s net income?
Marker Therapeutics, Inc. (MRKR) reported net income of -$12M for fiscal 2025.
Where can I see MRKR's net income history?
The chart and table above show Marker Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.